419P Minimal residual disease (MRD) detection in colorectal cancer (CRC) using a plasma-only integrated genomic and epigenomic circulating tumor DNA (ctDNA) assay

Authors :: V.M. Raymond
Ariel Jaimovich
Giulia Siravegna
Amir Ali Talasaz
Anna Hartwig
Aparna Raj Parikh
Ryan B. Corcoran
Genevieve M. Boland
E. Van Seventer
Source :: Annals of Oncology. 31:S419
Publication Year :: 2020
Publisher :: Elsevier BV, 2020.

Subjects :: Oncology
Circulating tumor DNA
business.industry
Colorectal cancer
Cancer research
Medicine
Hematology
business
medicine.disease
Minimal residual disease
Epigenomics

Full Text Access

Tools